Maturation of intracellular Escherichia coli communities requires SurA.
about
Intervening with urinary tract infections using anti-adhesives based on the crystal structure of the FimH-oligomannose-3 complexInsights into pilus assembly and secretion from the structure and functional characterization of usher PapCPpiA, a surface PPIase of the cyclophilin family in Lactococcus lactisUrinary Tract Infection: Pathogenesis and Outlook.Morphological plasticity promotes resistance to phagocyte killing of uropathogenic Escherichia coliSmall-molecule inhibitors target Escherichia coli amyloid biogenesis and biofilm formation.Components of SurA required for outer membrane biogenesis in uropathogenic Escherichia coli.Roles of putative type II secretion and type IV pilus systems in the virulence of uropathogenic Escherichia coli.Cj0596 is a periplasmic peptidyl prolyl cis-trans isomerase involved in Campylobacter jejuni motility, invasion, and colonization.Polysaccharide capsule and sialic acid-mediated regulation promote biofilm-like intracellular bacterial communities during cystitis.Virulence plasmid harbored by uropathogenic Escherichia coli functions in acute stages of pathogenesis.Metabolic Adaptations of Uropathogenic E. coli in the Urinary Tract.QseC-mediated dephosphorylation of QseB is required for expression of genes associated with virulence in uropathogenic Escherichia coli.A murine model of urinary tract infection.Microbial peptidyl-prolyl cis/trans isomerases (PPIases): virulence factors and potential alternative drug targets.How to make it in the urinary tract: a tutorial by Escherichia coliAberrant community architecture and attenuated persistence of uropathogenic Escherichia coli in the absence of individual IHF subunits.Proteome analysis and serological characterization of surface-exposed proteins of Rickettsia heilongjiangensisForced resurgence and targeting of intracellular uropathogenic Escherichia coli reservoirsDysregulation of Escherichia coli α-hemolysin expression alters the course of acute and persistent urinary tract infectionDNABII proteins play a central role in UPEC biofilm structureEstablishment and Characterization of UTI and CAUTI in a Mouse Model.Lead optimization studies on FimH antagonists: discovery of potent and orally bioavailable ortho-substituted biphenyl mannosidesInduction of indoleamine 2,3-dioxygenase by uropathogenic bacteria attenuates innate responses to epithelial infection.Combinatorial small-molecule therapy prevents uropathogenic Escherichia coli catheter-associated urinary tract infections in mice.Modulation of host innate immune response in the bladder by uropathogenic Escherichia coli.Immune modulation by group B Streptococcus influences host susceptibility to urinary tract infection by uropathogenic Escherichia coli.Association of O-Antigen Serotype with the Magnitude of Initial Systemic Cytokine Responses and Persistence in the Urinary Tract.The Activity of Escherichia coli Chaperone SurA Is Regulated by Conformational Changes Involving a Parvulin Domain.Brighter Fluorescent Derivatives of UTI89 Utilizing a Monomeric vGFPMolecular variations in Klebsiella pneumoniae and Escherichia coli FimH affect function and pathogenesis in the urinary tract.Utilization of an intracellular bacterial community pathway in Klebsiella pneumoniae urinary tract infection and the effects of FimK on type 1 pilus expressionImpact of the RNA chaperone Hfq on the fitness and virulence potential of uropathogenic Escherichia coli.The Yersiniabactin-Associated ATP Binding Cassette Proteins YbtP and YbtQ Enhance Escherichia coli Fitness during High-Titer Cystitis.Host-pathogen checkpoints and population bottlenecks in persistent and intracellular uropathogenic Escherichia coli bladder infection.LeuX tRNA-dependent and -independent mechanisms of Escherichia coli pathogenesis in acute cystitis.Androgens Enhance Male Urinary Tract Infection Severity in a New ModelDrug and Vaccine Development for the Treatment and Prevention of Urinary Tract Infections.Treatment and prevention of urinary tract infection with orally active FimH inhibitors.TLR-mediated immune responses in the urinary tract.
P2860
Q24645503-FC7E4137-AA7B-4C25-96A9-A6E9CA37C1DAQ27654975-17F33B85-EA5B-46F6-BA9F-7B5BA54D33FAQ28731225-77BF0DFB-6887-4963-B0D7-FD1B4CE75B73Q30244953-90F7B97B-9775-4AA7-9E1F-615227C43FB9Q30499366-F2C72374-8011-47E3-91E7-50E30A2B9A91Q30885749-CFFB9CAA-982A-4BF9-B7EC-462C810315DBQ33374005-89D1620E-9136-4763-819A-7952867A252FQ33415985-D9CFDBB3-D4F2-423D-9EC1-314F19B8C063Q33491815-A2E067B7-CBDF-4E50-96E3-B624C0829CB1Q33675852-47E2F8E8-F6EE-494A-A590-A99EC0E22470Q33769094-5B700418-69A5-4CF9-A9C6-C7D31C94DE1EQ33776967-E973E18B-67F8-489D-9870-6A9590766A94Q34235966-0F99C93D-9FCE-4F63-B6A1-933DC87CFA84Q34236010-DA7635FB-C2D9-43B5-B843-7C10EA733671Q34297821-2C0C5B56-9B29-4E2E-9653-68AFE204A5F6Q34440629-CAD4D191-C873-45C9-8E86-F0F5A0ECD74FQ34469467-3763B0AB-68C6-450E-98D3-2E932A117A95Q34876423-46A600DE-03CB-49C5-B267-525AEAA23A44Q35131385-0764F39D-77C3-4CB3-8B3F-0FD6B191296CQ35134655-07CBFA9C-6277-4DD8-8BA2-E7DCC3B3A882Q35732611-F1C9A85F-A90C-49DC-B228-81E4FE8CF89DQ35980554-1D588AB8-365B-472A-B32F-9300AB93E5B8Q36032748-DB36790C-CEA1-4374-B4C1-0DDF5DB25AEEQ36154064-DCDD71F4-CC25-48A3-9B28-7E934E630B4CQ36172411-C89A2406-1646-4B0D-A588-EE50AD9343E7Q36313895-48C37E03-6CC2-4C9E-8D10-7BC0A456E3D5Q36396848-1D680A33-95E2-453D-B75E-D36332D6DC52Q36634934-E00594C0-6813-453B-A3B2-35544F8D1AEDQ36634958-5577F89C-698E-4D73-AEFD-AF50D007F783Q36735383-A8EA9E45-BF3F-408D-9639-74DEEC911B24Q36747046-4629F198-1ADC-4703-8AC8-9427FBA58DA2Q36747152-825DA99C-3298-44FC-B06C-199EF92AA407Q36747192-8F554553-C809-40FD-9E83-D280E85C7551Q36888554-323D69B6-BBC8-4353-BB7F-578A256C4358Q36910650-84B640A5-ED10-4F29-9265-A55FE5453878Q36911129-DAC85B2D-8854-4352-B718-E368C18A22DAQ36944667-324BF913-C16C-4E66-9AA1-825B2F7B360EQ36951570-C7A63FBE-2E80-4E7B-8EEE-8B4ED4469A50Q36961034-8B2EA372-2D63-4632-806C-EE6ABD1C8E91Q37074933-52FB2BC4-CF9E-4242-B87E-29AD144C1163
P2860
Maturation of intracellular Escherichia coli communities requires SurA.
description
2006 nî lūn-bûn
@nan
2006 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
name
Maturation of intracellular Escherichia coli communities requires SurA.
@ast
Maturation of intracellular Escherichia coli communities requires SurA.
@en
Maturation of intracellular Escherichia coli communities requires SurA.
@nl
type
label
Maturation of intracellular Escherichia coli communities requires SurA.
@ast
Maturation of intracellular Escherichia coli communities requires SurA.
@en
Maturation of intracellular Escherichia coli communities requires SurA.
@nl
prefLabel
Maturation of intracellular Escherichia coli communities requires SurA.
@ast
Maturation of intracellular Escherichia coli communities requires SurA.
@en
Maturation of intracellular Escherichia coli communities requires SurA.
@nl
P2860
P356
P1476
Maturation of intracellular Escherichia coli communities requires SurA
@en
P2093
Scott R Lauer
Sheryl S Justice
P2860
P304
P356
10.1128/IAI.00355-06
P407
P577
2006-08-01T00:00:00Z